Home Newsfeeds Barclays Maintains Equal-Weight on GMS, Raises Price Target to $67

Barclays Maintains Equal-Weight on GMS, Raises Price Target to $67

Barclays analyst Matthew Bouley maintains GMS (NYSE:GMS) with a Equal-Weight and raises the price target from $60 to $67.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Barclays analyst Matthew Bouley maintains GMS (NYSE:GMS) with a Equal-Weight and raises the price target from $60 to $67.

DA Davidson Maintains Buy on Marathon Digital Holdings, Lowers Price Target to $22

By Benzinga Newsdesk

September 15, 8:20 AM

DA Davidson analyst Chris Brendler maintains Marathon Digital Holdings (NASDAQ:MARA) with a Buy and lowers the price target from $30 to $22.

MARA

House of the ‘House of the Dragon’ Is On Fire: Why Is Warner Bros. Discovery Stock Tanking?

By Chris Katje

August 5, 4:56 PM

Since being spun off from AT&T Inc. (NYSE: T), media company Warner Bros. Discovery (NASDAQ: WBD) has seen shares fall. An earnings report and a new strategy shift are sending shares down further Friday.

DIS

Rocket Pharma COO On Observing Rare Disease Day, And Why It Deserves US Attention

By Anthony Noto

February 28, 3:34 PM

Feb. 28 is Rare Disease Day. It's meant to observe the more than 400 million people globally — 50% of them children — that are affected by rare, pediatric life-threatening diseases such as leukemia, Cystic Fibrosis and Hemophilia to name a few.

RCKT